UBS AM’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-19,800
| Closed | -$73K | – | 2653 |
|
|
2016
Q1 | $73K | Sell |
19,800
-2,277
| -10% | -$8.4K | ﹤0.01% | 2597 |
|
|
2015
Q4 | $223K | Sell |
22,077
-3,500
| -14% | -$35.4K | ﹤0.01% | 2477 |
|
|
2015
Q3 | $348K | Buy |
25,577
+9,800
| +62% | +$133K | ﹤0.01% | 2212 |
|
|
2015
Q2 | $299K | Sell |
15,777
-361,600
| -96% | -$6.85M | ﹤0.01% | 2366 |
|
|
2015
Q1 | $9.88M | Buy |
377,377
+500
| +0.1% | +$13.1K | 0.01% | 886 |
|
|
2014
Q4 | $7.89M | Sell |
376,877
-72,700
| -16% | -$1.52M | 0.01% | 932 |
|
|
2014
Q3 | $15M | Buy |
449,577
+20,214
| +5% | +$675K | 0.01% | 747 |
|
|
2014
Q2 | $13.8M | Buy |
429,363
+51,786
| +14% | +$1.66M | 0.01% | 768 |
|
|
2014
Q1 | $17.4M | Buy |
377,577
+249,400
| +195% | +$11.5M | 0.02% | 702 |
|
|
2013
Q4 | $9.1M | Sell |
128,177
-5,300
| -4% | -$376K | 0.01% | 846 |
|
|
2013
Q3 | $11.4M | Sell |
133,477
-127,676
| -49% | -$10.9M | 0.01% | 775 |
|
|
2013
Q2 | $16.5M | Buy |
+261,153
| New | +$16.5M | 0.02% | 626 |
|